These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9794158)

  • 1. [Limits of brief treatment of onychomycoses].
    Seebacher C
    Hautarzt; 1998 Sep; 49(9):705-8. PubMed ID: 9794158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Lamisil and azole antifungals in experimental nail infection.
    Richardson MD
    Dermatology; 1997; 194 Suppl 1():27-31. PubMed ID: 9154398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
    De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open randomized comparison of itraconazole versus terbinafine in onychomycosis.
    Arenas R; Domínguez-Cherit J; Fernández LM
    Int J Dermatol; 1995 Feb; 34(2):138-43. PubMed ID: 7737776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itraconazole versus terbinafine in the management of onychomycosis: an overview.
    Jain S; Sehgal VN
    J Dermatolog Treat; 2003 Jan; 14(1):30-42. PubMed ID: 12745853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of oral antifungal agents to treat onychomycosis.
    Gupta AK; Ryder JE
    Dermatol Clin; 2003 Jul; 21(3):469-79, vi. PubMed ID: 12956199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
    Sarifakioglu E; Seçkin D; Demirbilek M; Can F
    Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine.
    Zaias N; Rebell G
    Arch Dermatol; 2004 Jun; 140(6):691-5. PubMed ID: 15210459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
    Bradley MC; Leidich S; Isham N; Elewski BE; Ghannoum MA
    Mycoses; 1999; 42 Suppl 2():105-10. PubMed ID: 10865915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
    Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
    Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails.
    Bräutigam M
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S53-6. PubMed ID: 9594938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onychomycosis--treatment, relapse and re-infection.
    Hull PR
    Dermatology; 1997; 194 Suppl 1():7-9. PubMed ID: 9154393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.
    Kejda J
    Postgrad Med; 1999 Jul; Spec No():12-5. PubMed ID: 10492661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onychomycosis treated until the nail is replaced by normal growth or there is failure.
    Zaias N; Rebell G; Zaiac MN; Glick B
    Arch Dermatol; 2000 Jul; 136(7):940. PubMed ID: 10891008
    [No Abstract]   [Full Text] [Related]  

  • 16. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onychomycosis: clinical, mycological and in vitro susceptibility testing of isolates of Trichophyton rubrum.
    Azambuja CV; Pimmel LA; Klafke GB; Xavier MO
    An Bras Dermatol; 2014; 89(4):581-6. PubMed ID: 25054744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichophyton rubrum DNA strain switching increases in patients with onychomycosis failing antifungal treatments.
    Gupta AK; Nakrieko KA
    Br J Dermatol; 2015 Jan; 172(1):74-80. PubMed ID: 24903451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US.
    Van Duyn Graham L; Elewski BE
    Mycoses; 2011 Nov; 54(6):e679-85. PubMed ID: 21668517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up.
    Tosti A; Piraccini BM; Stinchi C; Colombo MD
    Dermatology; 1998; 197(2):162-6. PubMed ID: 9732167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.